ScholarIQanswers from OpenAlex

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

PaperCitations, authors & open-access status

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events is a paper indexed in ScholarIQ from OpenAlex.

How many citations does P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events have?

ScholarIQcitation count

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events has 182 citations in the OpenAlex counts ScholarIQ stores.

When was P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events published?

ScholarIQyear

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events has 2023 year in the ScholarIQ index.

What is the open-access status of P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events?

ScholarIQoa status

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events has closed oa status in the ScholarIQ index.

What is the DOI of P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events?

ScholarIQdoi

The DOI for P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events is on the source record.

What is the PMID of P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events?

ScholarIQpmid

The PMID for P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events is on the source record.

What is the OpenAlex record for P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events?

ScholarIQopenalex

The OpenAlex for P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial